RAPT Therapeutics Inc (RAPT)
7.90
-0.10
(-1.25%)
USD |
NASDAQ |
Apr 24, 16:00
7.92
+0.02
(+0.25%)
After-Hours: 20:00
RAPT Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | 3.249M |
| March 31, 2022 | 3.232M |
| December 31, 2021 | 3.813M |
| September 30, 2021 | 4.359M |
| Date | Value |
|---|---|
| June 30, 2021 | 4.921M |
| March 31, 2021 | 5.329M |
| December 31, 2020 | 5.042M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.232M
Minimum
Mar 2022
5.329M
Maximum
Mar 2021
4.278M
Average
4.359M
Median
Sep 2021
Revenue (TTM) Benchmarks
| Emergent BioSolutions Inc | 1.024B |
| Avinger Inc | 7.652M |
| Tonix Pharmaceuticals Holding Corp | -- |
| Skye Bioscience Inc | -- |
| Axsome Therapeutics Inc | 270.60M |